Relationship of Brain Natriuretic Peptide Concentrations to Left Ventricular Function and Adverse Outcomes in Children With End-Stage Renal Disease Undergoing Hemodialysis

2011 ◽  
Vol 32 (5) ◽  
pp. 568-577 ◽  
Author(s):  
Sana Ouali ◽  
Iheb Bougmiza ◽  
Saoussen Abroug ◽  
Asma Omezzine ◽  
Helmi Ben Salem ◽  
...  
Keyword(s):  
Renal Disease ◽  
Brain Natriuretic Peptide ◽  
Left Ventricular Function ◽  
Ventricular Function ◽  
End Stage Renal Disease ◽  
Left Ventricular ◽  
Adverse Outcomes ◽  
Stage Renal Disease ◽  
End Stage ◽  
Relationship Of

scholarly journals Effect of maintenance hemodialysis on diastolic left ventricular function in end-stage renal disease

Clinics ◽  
2010 ◽  
Vol 65 (10) ◽  
pp. 979-984 ◽  
Author(s):  
Mustafa Duran ◽  
Aydin Unal ◽  
Mehmet Tugrul Inanc ◽  
Fatma Esin ◽  
Yucel Yilmaz ◽  
...  
Keyword(s):  
Renal Disease ◽  
Left Ventricular Function ◽  
Ventricular Function ◽  
End Stage Renal Disease ◽  
Left Ventricular ◽  
Maintenance Hemodialysis ◽  
Diastolic Left Ventricular Function ◽  
Stage Renal Disease ◽  
End Stage

The effects of dialysis-type on left ventricular function in non-diabetic end-stage renal disease patients

2016 ◽  
Vol 71 (6) ◽  
pp. 706-706 ◽  
Author(s):  
Zeki Yüksel Günaydin ◽  
Ahmet Karagöz ◽  
Osman Bektaş ◽  
Mehmet Baran Karataş ◽  
Ahmet Karataş ◽  
...  
Keyword(s):  
Renal Disease ◽  
Left Ventricular Function ◽  
Ventricular Function ◽  
End Stage Renal Disease ◽  
Left Ventricular ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals CA 125 levels and left ventricular function in patients with end-stage renal disease on maintenance hemodialysis

Renal Failure ◽  
2013 ◽  
Vol 36 (2) ◽  
pp. 210-216 ◽  
Author(s):  
Hakki Yilmaz ◽  
Ozgül Malcok Gürel ◽  
Hüseyin Tugrul Çelik ◽  
Enes Şahiner ◽  
Mehmet Erol Yildirim ◽  
...  
Keyword(s):  
Renal Disease ◽  
Left Ventricular Function ◽  
Ventricular Function ◽  
End Stage Renal Disease ◽  
Left Ventricular ◽  
Ca 125 ◽  
Maintenance Hemodialysis ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Impact of parathyroidectomy on left ventricular function in end stage renal disease patients

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Shaohua Chen ◽  
Kaixiang Sheng ◽  
Ying Shen ◽  
Hua Jiang ◽  
Xin Lei ◽  
...  
Keyword(s):  
Left Ventricular Function ◽  
Ventricular Function ◽  
End Stage Renal Disease ◽  
Systolic Function ◽  
Left Ventricular Systolic Function ◽  
Left Ventricular ◽  
Ventricular Systolic Function ◽  
Stage Renal Disease ◽  
End Stage ◽  
Esrd Patients

Abstract Background Secondary hyperparathyroidism (SHPT) is a common complication in end-stage renal disease (ESRD) patients, and parathyroidectomy (PTX) is an effective treatment intervention of SHPT. However, the curative impact of PTX on left ventricular function still remains incompletely understood. To evaluate the impact of parathyroidectomy on left ventricular function in ESRD patients, we conducted this retrospective study. Methods Between Oct 1, 2010 and Oct 1, 2016, ESRD patients presented with SHPT who underwent parathyroidectomy were enrolled. We retrospectively collected the ultrasonic cardiogram parameter pre- and 1-year post-PTX, and analyzed the influence factor for the overturn of left ventricular hypertrophy (LVH) and the improvement of ejection fraction% (EF%). Results In all the patients (135), the main ultrasonic cardiogram parameter dramatically improved after PTX. Compared with pre-PTX, the left ventricular mass (LVM) (172.82 (135.90, 212.91) g vs. 192.76 (157.56, 237.97) g, p<0.001) and the left ventricular mass index (LVMI) (107.01 (86.79, 128.42) g/m2 vs. 123.54 (105.49, 146.64) g/m2, p<0.001) significantly declined after 1 year of the PTX. Further, 43.75% patients diagnosed with LVH before the PTX have recovered from LVH. In the subgroup analysis of 35 patients with EF% ≤ 60% pre-PTX, EF% and fractional shortening% (FS%) significantly improved after 1 year of the PTX compared with pre-PTX (EF%: 64.90 ± 7.90% vs. 55.71 ± 4.78%, p<0.001; FS% 35.48 ± 6.34% vs. 29.54 ± 2.88%, p<0.001), and 82.86% patients underwent an improvement of left ventricular systolic function post 1year of the PTX. Conclusions tPTX+AT is an effective curative intervention of secondary hyperparathyroidism and can significantly overturn the LVH and increase the left ventricular systolic function.

scholarly journals Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ashwin Radhakrishnan ◽  
Luke C. Pickup ◽  
Anna M. Price ◽  
Jonathan P. Law ◽  
Kirsty C. McGee ◽  
...  
Keyword(s):  
Confidence Interval ◽  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Microvascular Dysfunction ◽  
Left Ventricular ◽  
Coronary Microvascular Dysfunction ◽  
Transplant Candidates ◽  
Stage Renal Disease ◽  
End Stage

Abstract Background Coronary microvascular dysfunction (CMD) is common in end-stage renal disease (ESRD) and is an adverse prognostic marker. Coronary flow velocity reserve (CFVR) is a measure of coronary microvascular function and can be assessed using Doppler echocardiography. Reduced CFVR in ESRD has been attributed to factors such as diabetes, hypertension and left ventricular hypertrophy. The contributory role of other mediators important in the development of cardiovascular disease in ESRD has not been studied. The aim of this study was to examine the prevalence of CMD in a cohort of kidney transplant candidates and to look for associations of CMD with markers of anaemia, bone mineral metabolism and chronic inflammation. Methods Twenty-two kidney transplant candidates with ESRD were studied with myocardial contrast echocardiography, Doppler CFVR assessment and serum multiplex immunoassay analysis. Individuals with diabetes, uncontrolled hypertension or ischaemic heart disease were excluded. Results 7/22 subjects had CMD (defined as CFVR < 2). Demographic, laboratory and echocardiographic parameters and serum biomarkers were similar between subjects with and without CMD. Subjects with CMD had significantly lower haemoglobin than subjects without CMD (102 g/L ± 12 vs. 117 g/L ± 11, p = 0.008). There was a positive correlation between haemoglobin and CFVR (r = 0.7, p = 0.001). Similar results were seen for haematocrit. In regression analyses, haemoglobin was an independent predictor of CFVR (β = 0.041 95% confidence interval 0.012–0.071, p = 0.009) and of CFVR < 2 (odds ratio 0.85 95% confidence interval 0.74–0.98, p = 0.022). Conclusions Among kidney transplant candidates with ESRD, there is a high prevalence of CMD, despite the absence of traditional risk factors. Anaemia may be a potential driver of microvascular dysfunction in this population and requires further investigation.

Sign in / Sign up

Export Citation Format

Share Document